课题基金 / 基金详情

MOLECULAR MECHANISMS OF HYPERGLYCEMIA AND DIABETES-INDUCED MONOCYTE ACT

MOLECULAR MECHANISMS OF HYPERGLYCEMIA AND DIABETES-INDUCED MONOCYTE ACT
高血糖和糖尿病引起的单核细胞活性的分子机制
批准号:
7603861
负责人:
RAMA NATARAJAN
金额:
$0.39万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

RAMA NATARAJAN的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is designed to determine the mechanisms responsible for the high rates (3-4 fold) of cardiovascular (heart and blood vessels) complications in the Type I and Type II diabetic population. The adhesion of blood monocytes to the vessel wall, migration into the blood vessel and uptake of fat particles, such as the bad fraction of cholesterol, known as LDL cholesterol, are some of the earliest events in the clogging of blood vessels which can lead to heart attacks. This study is designed to determine how elevated blood glucose levels (hyperglycemia) and high fat levels (hyperlipidemia) can worsen these processes. Our earlier studies have shown that culture of normal monocytes under hyperglycemia conditions can alter genes and make them behave abnormally. The comparison of isolated monocytes from healthy volunteers versus patients with Type I and Type II diabetes may help to improve our understanding of the disease process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAINING
Epigenetic Markers of Complications and Metabolic Memory in the DCCT/EDIC cohort.
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells
海外基金